Tumour-cell apoptosis after cisplatin treatment is not telomere dependent

15Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

Abstract

Cisplatin is a major chemotherapeutic agent, especially for the treatment of neuroblastoma. Telomeres with their sequence (TTAGGG)n are probable targets for cisplatin intrastrand cross-linking, but the role of telomeres in mediating cisplatin cytotoxicity is not clear. After exposure to cisplatin as single dose or continuous treatment, we found no loss of telomeres in either SHSY5Y neuroblastoma cells (telomere length, ∼4 kbp), HeLa 229 cells (telomere length, 20 kbp) or in the acute lymphoblastic T cell line 1301 (telomere length, ∼80 kbp). There was no induction of telomeric single strand breaks, telomeric overhangs were not degraded and telomerase activity was down-regulated only after massive onset of apoptosis. In contrast, cisplatin induced a delayed formation of DNA strand breaks and induced DNA damage foci containing γ-H2A.X at nontelomeric sites. Interstitial DNA damage appears to be more important than telomere loss or telomeric damage as induce r of the signal pathway towards apoptosis and/or growth arrest in cisplatin-treated tumour cells. © 2005 Wiley-Liss, Inc.

Cite

CITATION STYLE

APA

Jeyapalan, J. C., Saretzki, G., Leake, A., Tilby, M. J., & Von Zglinicki, T. (2006). Tumour-cell apoptosis after cisplatin treatment is not telomere dependent. International Journal of Cancer, 118(11), 2727–2734. https://doi.org/10.1002/ijc.21675

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free